Global Blood Testing Market

Blood Testing Market Size, Share, Growth Analysis, By Type (Glucose Testing, Lipid Panel Testing), By Methods (Manual Blood Testing, Automated Blood Testing), By End User, By Region - Industry Forecast 2025-2032


Report ID: SQMIG35A2519 | Region: Global | Published Date: December, 2024
Pages: 157 | Tables: 66 | Figures: 75

Blood Testing Market News

  • In March 2022, AXIM Biotechnologies Inc., an International healthcare solutions firm focused on dry eye disease, changed their concentration for COVID-19 Neutralizing Antibody Test to for only research use.
  • In May 2022, the company Guardant Health Inc. announce the availability of shield, which is a blood based test for the detection of early stage colorectal cancer (CRC).
  • In February 2022, Tasso, a manufacturer of portable blood collection devices, partnered with telemedicine company Vault Health to help enable diagnostic test functions at home.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Blood Testing Market size was valued at USD 95.94 Billion in 2023 and is poised to grow from USD 103.14 Billion in 2024 to USD 183.94 Billion by 2032, growing at a CAGR of 7.5% during the forecast period (2025-2032).

The global blood testing market is highly fragmented in the nature with the presence of several big players such as Danaher Corporation, Abbott Laboratories, BioRad Laboratories. These key players are implanting on certain strategies such as merger, acquisition, new product launch, partnerships, which help them to consolidate and strengthening their market position. For instance, in June 2022, Apollo Cancer Centres in partnership with Datar Cancer Genetics launched a type of blood test that can detect breast cancer at early stages in asymptomatic individuals. 'Abbott ', 'F. Hoffmann-La Roche Ltd ', 'Bio-Rad Laboratories, Inc. ', 'bioMerieux ', 'Quest Diagnostics Incorporated ', 'Biomerica ', 'BD ', 'Siemens Healthineers AG ', 'Danaher Corporation ', 'Trinity Biotech Plc ', 'Thermo Fisher Scientific ', 'Sysmex Corporation ', 'Dr Lal PathLabs Limited ', 'Alere Inc. ', 'Cepheid Corporation '

External funding for the clinical studies aimed at developing new and advanced technology in diagnostic tests is a major driver to the growth of the market.

Key players in the global blood testing market are focusing on new and innovative ways to make their products and to introduce more effectively for the end-users. The use of latest technology such as Artificial Intelligence to detect accurate results at early stage of a disease is having positive impact on the end-users.

North America dominated the global blood testing market and accounted for the largest revenue share of over 45% in 2021. A rise in the number of strategic activities which are being undertaken by several market players and government bodies to increase the donation of plasma in the region is one of the major factors driving the market growth over the forecast period. The United States topped in the export value blood testing instruments in 2021. In the United States, the export value for blood testing instruments was USD 27,782,430 thousand in 2020 which rises to USD 30,967,176 thousand in 2021 with an annual growth rate of 11%. The increasing number of blood donations is further anticipated to fuel the demand for the testing products in the region.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Blood Testing Market

Report ID: SQMIG35A2519

$5,300
BUY NOW GET FREE SAMPLE